Jan Stenvang
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 2%
- Circular RNAs in diseases
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
- RNA modifications and cancer
- Extracellular vesicles in disease
- RNA Research and Splicing
Papers in
-
- Cancer therapeutics and mechanisms 20
- RNA Interference and Gene Delivery 10
- Advanced biosensing and bioanalysis techniques 8
- Oncology 43
- Colorectal Cancer Treatments and Studies 12
- Drug Transport and Resistance Mechanisms 12
- Cancer Treatment and Pharmacology 9
- Co-authors
- Sakari Kauppinen (10 shared papers)Morten Lindow (4 shared papers)Susanna Obad (4 shared papers)Andreas Petri (3 shared papers)Jesper Wengel (5 shared papers)Simon Fredriksson (4 shared papers)Martin Lundberg (3 shared papers)Erika Assarsson (2 shared papers)
- Journals
- BMC Cancer (6 papers)Cancer Research (5 papers)Journal of Clinical Oncology (5 papers)Scientific Reports (4 papers)Molecular Cancer Therapeutics (4 papers)
- Partner nations
- DenmarkChinaUnited States
In The Last Decade
Jan Stenvang
91 papers receiving 5.3k citations
Jan Stenvang's Hit Papers
Peers
Comparison fields: 5 of 136
- Cancer Research 2.1k
- Molecular Biology 3.4k
- Oncology 802
- Immunology 597
- Genetics 225
Countries citing papers authored by Jan Stenvang
This map shows the geographic impact of Jan Stenvang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Stenvang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Stenvang more than expected).
Fields of papers citing papers by Jan Stenvang
This network shows the impact of papers produced by Jan Stenvang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Stenvang. The network helps show where Jan Stenvang may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan Stenvang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 93 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability Hit paper breakdown → | 2014 | 1147 |
| 2 | 2011 | 498 | |
| 3 | 2012 | 435 | |
| 4 | 2011 | 411 | |
| 5 | 2010 | 260 | |
| 6 | 2009 | 163 | |
| 7 | 2008 | 151 | |
| 8 | 2004 | 145 | |
| 9 | 2008 | 130 | |
| 10 | 2017 | 102 | |
| 11 | 2017 | 102 | |
| 12 | 2016 | 100 | |
| 13 | 2012 | 93 | |
| 14 | 2016 | 92 | |
| 15 | 2007 | 86 | |
| 16 | 2013 | 79 | |
| 17 | 1999 | 71 | |
| 18 | 2017 | 65 | |
| 19 | LNA-antisense rivals siRNA for gene silencing. | 2004 | 61 |
| 20 | 2017 | 49 |
About Jan Stenvang
Jan Stenvang is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Surgery, having authored 93 papers that have together received 5.4k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (20 papers), MicroRNA in disease regulation (18 papers), Colorectal Cancer Treatments and Studies (12 papers), Drug Transport and Resistance Mechanisms (12 papers), RNA Interference and Gene Delivery (10 papers), Cancer-related molecular mechanisms research (10 papers), Cancer Treatment and Pharmacology (9 papers) and Advanced biosensing and bioanalysis techniques (8 papers). The work is most often cited by research in Cancer Research (2.1k citations), Molecular Biology (3.4k citations), Oncology (802 citations), Immunology (597 citations) and Genetics (225 citations). Jan Stenvang has collaborated with scholars based in Denmark, China and United States. Frequent co-authors include Sakari Kauppinen, Morten Lindow, Susanna Obad, Andreas Petri, Jesper Wengel, Simon Fredriksson, Martin Lundberg, Erika Assarsson, Ann‐Catrin Andersson and Anna Eriksson. Their work appears in journals such as BMC Cancer, Cancer Research, Journal of Clinical Oncology, Scientific Reports and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.